DGX · Quest Diagnostics Inc
United States · RS rating 89 · As of 2026-11-03
| Price | 247.06 USD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 76 / 76 / 82 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 57 / 51 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +0.9% |
| Sales growth Q/Q | -0.4% |
| Distance from 52-week high | +2.3% |
| Market cap (USD) | $22.1B |